FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|May 13, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 13, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 46.6% of total US population has received at least 1 dose
• 35.8% of total US population is fully vaccinated
• 35.8% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 47.3%
2. Connecticut: 46.5%
3. Massachusetts: 44.8%
4. Vermont: 44.8%
5. Rhode Island: 43.4%
2. Connecticut: 46.5%
3. Massachusetts: 44.8%
4. Vermont: 44.8%
5. Rhode Island: 43.4%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 844 759 confirmed cases
• 584 346 deaths
• 584 346 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 763 566
2. Texas: 2 924 188 3. Florida: 2 282 613
4. New York: 2 079 749
5. Illinois: 1 361 569
2. Texas: 2 924 188 3. Florida: 2 282 613
4. New York: 2 079 749
5. Illinois: 1 361 569
Deaths: California has the most deaths due to COVID-19 with 62 516 reported fatalities, followed by New York with 52 866, and Texas with 50 836.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 160 743 894 confirmed cases, 3 338 355 deaths, and 1 380 053 686 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
3
Multicomponent Strategies to Ease Vaccination Pain and Fear Across Ages
4
FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke
5